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a  b  s  t  r  a  c  t
Non-coding  RNAs  are  involved  in a multitude  of cellular  processes  but  the biochemical  function  of  many
small  non-coding  RNAs  remains  unclear.  The  family  of  small  non-coding  Y RNAs  is conserved  in ver-
tebrates  and related  RNAs  are present  in some  prokaryotic  species.  Y RNAs  are also  homologous  to  the
newly  identiﬁed  family  of  non-coding  stem-bulge  RNAs  (sbRNAs)  in nematodes,  for  which  potential  phys-
iological  functions  are only  now  emerging.  Y RNAs  are  essential  for  the initiation  of chromosomal  DNA
replication  in vertebrates  and, when  bound  to the  Ro60  protein,  they  are  involved  in RNA  stability  and
cellular  responses  to stress  in several  eukaryotic  and  prokaryotic  species.  Additionally,  short  fragments
of Y RNAs  have  recently  been  identiﬁed  as  abundant  components  in the  blood  and  tissues of  humans
and  other  mammals,  with  potential  diagnostic  value.  While  the  number  of  functional  roles  of  Y  RNAs  isNA stability
NA domains
growing,  it  is becoming  increasingly  clear  that  the  conserved  structural  domains  of Y RNAs  are  essential
for  distinct  cellular  functions.  Here,  we review  the biochemical  functions  associated  with  these  struc-
tural  RNA  domains,  as  well  as  the  functional  conservation  of Y  RNAs in different  species.  The  existing
biochemical  and  structural  evidence  supports  a  domain  model  for  these  small  non-coding  RNAs  that  has
direct  implications  for the  modular  evolution  of functional  non-coding  RNAs.
©  2015  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction and historical overview
Small non-coding Y RNAs were ﬁrst discovered in 1981 as com-
ponents of ribonucleoproteins (RNPs) complexed with Ro60 and
La proteins, autoantigens which are targets of the immune system
in patients suffering from the autoimmune diseases systemic lupus
erythematosus (SLE) and Sjögren’s syndrome (Hendrick et al., 1981;
Lerner et al., 1981). These non-coding RNAs were initially found in
the cytoplasm of mammalian cells (human, mouse and monkey)
and were therefore given the preﬁx ‘Y’, for cytoplasmic Y RNAs, to
distinguish them from nuclear U RNAs (Lerner et al., 1981).
There are four non-coding Y RNAs in humans (hY1, hY3, hY4 and
hY5 RNA; an hY2 RNA was  also originally described, but was  later
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. The non-coding human Y RNAs. The nucleotide sequences and secondary structures of hY RNAs are derived from sequence alignment and enzymatic and chemical
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Rrobing (Teunissen et al., 2000; van Gelder et al., 1994). The conserved structural R
ucleotides (nt) and molecular weight (kDa) of each RNA is indicated. See main tex
emoved from the list as it was found to be a degradation product
f hY1 RNA). Y RNAs are present in all vertebrate species investi-
ated so far, with between one and four different genes per species
eﬂecting gene loss and duplication events during vertebrate evo-
ution (Mosig et al., 2007; Perreault et al., 2007). In humans, the
our Y RNA genes are clustered together at a single chromosomal
ocus on chromosome 7q36 (Maraia et al., 1994, 1996). A similar
yntenic arrangement of Y RNA genes has been described in other
ertebrates (Farris et al., 1996; O’Brien et al., 1993). Individual Y
NA genes are transcribed by RNA polymerase III from distinct pro-
oters (Hendrick et al., 1981; Wolin and Steitz, 1983). Y RNAs are
elatively small at 100 ± 20 nucleotides in size, and fold into char-
cteristic stem-loop secondary structures (Fig. 1). Chemical and
nzymatic structure probing experiments have revealed that the 5′
nd 3′ RNA ends hybridise to form predominantly double-stranded
pper and lower stem domains with an internal loop (Teunissen
t al., 2000; van Gelder et al., 1994). The nucleotide sequences
f the lower and upper stems are highly conserved, whereas the
equences – and hence predicted structures – of the internal loop
ary greatly between individual Y RNAs.
The existence of Y RNAs is not restricted to vertebrates. The fam-
ly of small non-coding stem-bulge RNAs (sbRNAs) in nematodes
as recently been shown to be homologous in structure and func-
ion to vertebrate Y RNAs (Boria et al., 2010; Kowalski et al., 2015).
mall non-coding RNAs bearing similarities to vertebrate Y RNAs
r nematode sbRNAs have also been reported in other eukaryotes,
ncluding the insects Anopheles gambiae (Perreault et al., 2007) and
ombyx mori (Duarte et al., 2015), and the lancet Branchiostoma
oridae (Mosig et al., 2007). Similar RNAs have also been described
n some prokaryotes, including Deinococcus radiodurans (Chen et al.,
000), Salmonella enterica serovar Typhimurium (Chen et al., 2013),
ycobacterium smegmatis and possibly many more (Chen et al.,
014). These bacterial RNAs are highly divergent from, and not
omologous with, the four vertebrate Y RNA clades (Perreault et al.,
007).Since their discovery in 1981, the Y RNA ﬁeld has grown consid-
rably, concomitant with the rise in number of independent cellular
oles associated with Y RNAs (Fig. 2). Biochemical functions of Y
NAs have been mapped to distinct structural domains of the Ymains and their associated functions are highlighted for each hY RNA. The size in
eferences.
and sbRNAs. Therefore, to reconcile this diverse range of functions,
a concept of modular structure and evolution of these RNAs is now
becoming apparent (Fig. 3).
Initially, investigations into Y RNA function focussed on the con-
served binding sites for Ro60 and La proteins, which are required for
Y RNAs to associate with these proteins to form RoRNPs (Chen and
Wolin, 2004). RoRNPs are currently implicated in RNA processing
and quality control (Hall et al., 2013; Wolin et al., 2012). The precise
cellular function of RoRNPs is not yet clear and furthermore they
are not essential as deletion mutants of Ro60 are viable. The highly
conserved binding sites for Ro60 and La proteins are present in the
lower stem and polyuridine tail domains of Y RNAs, respectively
(Fig. 1).
More recently Y RNAs were shown to be essential factors for
the initiation step of chromosomal DNA replication in human cell
nuclei (Christov et al., 2006; Krude et al., 2009). Strikingly, the
essential cellular function of Y RNAs in DNA replication is conserved
in vertebrates and nematodes, since functional inactivation of Y
RNAs in Xenopus laevis and Danio rerio embryos, or of sbRNAs in
Caenorhabditis elegans leads to abrogation of DNA replication, cell
cycle arrest and embryonic lethality (Collart et al., 2011; Kowalski
et al., 2015). In contrast to Ro60 and La binding, this essential func-
tion resides in the upper stem domain of these RNAs (Gardiner et al.,
2009; Kowalski et al., 2015; Wang et al., 2014).
The loop domain of Y RNAs is diverse in sequence and has been
reported to bind several different proteins, including nucleolin,
polypyrimidine tract-binding protein (PTB) and zipcode binding
protein 1 (ZBP1) (Köhn et al., 2013) (Fig. 1). The roles of the inter-
actions with these proteins are unclear, but it has been suggested
that they could modulate the subcellular localisation of Ro60 (Sim
and Wolin, 2011), and also confer specialised cellular functions by
binding preferentially to speciﬁc Y RNAs (Hogg and Collins, 2007;
Langley et al., 2010). Consistent with its wide array of binding
proteins, the loop domain has been implicated in modulating the
association of Y RNAs with subnuclear chromatin domains (Zhang
et al., 2011).
Finally, small RNA fragments derived from Y RNAs become
enriched in apoptotic cells, possibly as result of apoptotic
degradation processes (Rutjes et al., 1999). However, recent
22 M.P. Kowalski, T. Krude / The International Journal of Biochemistry & Cell Biology 66 (2015) 20–29
Fig. 2. Approximate number of publications per year relating to small non-coding RNA (left y-axis) and Y RNA (right y-axis), respectively. Data are the number of hits on
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r Thomson Reuters Web  of Science topic search for the phrases ‘small non-coding
haracters).
igh-throughput RNA sequencing approaches have now estab-
ished that small Y RNA fragments are also highly abundant in cells,
issues and body ﬂuids of humans and mammals, as well as in a
ange of tumours (Dhahbi et al., 2014; Meiri et al., 2010; Nicolas
t al., 2012; Vojtech et al., 2014). Therefore, these Y RNA-derived
ragments are now of clinical interest and have attracted much
ecent attention as potential biomarkers for disease.
In this review, we discuss the biochemical and cellular func-
ions of Y RNAs, as well as their evolutionary conservation. The
eader is referred to earlier reviews that have focused on individ-
al aspects of Y RNA and RoRNP biology (Chen and Wolin, 2004;
all et al., 2013; Köhn et al., 2013; Krude, 2010; Pruijn et al., 1997;
erhagen and Pruijn, 2011; Wolin et al., 2012, 2013). Here, we
resent a current integrated view of Y RNA function, focussing on
he modular domain structure of Y RNAs, which can mediate the
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2. Y RNAs form RoRNPs that are involved in the regulation
of RNA stability and cellular stress responses
Y RNAs were ﬁrst identiﬁed as non-coding RNAs bound by the
Ro60 protein, a common 60 kDa antigen detected by antibodies
from patients with the autoimmune diseases Systemic Lupus Ery-
thematosus and Sjögren’s syndrome (Lerner et al., 1981). Ro60 is
conserved in vertebrates and homologues have been identiﬁed in
most metazoa, and also in ∼5% of sequenced bacterial genomes,
including D. radiodurans and Salmonella (Sim and Wolin, 2011;
Wolin et al., 2013).
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In all organisms studied, orthologues of Ro60 protein bind to Y
NAs, or Y RNA-like (Yrl) non-coding RNAs to form RoRNPs (Chen
t al., 2013, 2014) (Fig. 3). In vertebrates, the Ro60 binding site
n the lower stem domain of Y RNAs is well characterised and
omprises a seven-base-pair helix, a single bulged cytidine and a
hree-nucleotide bulge on the opposite strand (Pruijn et al., 1991;
olin and Steitz, 1984) (Fig. 1). In vertebrates, Ro60-binding to
he Y RNA lower stem is dependent on both RNA sequence-speciﬁc
nteractions and shape complementarity (Stein et al., 2005). The
wo bulges in the lower stem of Y RNAs distort its helical struc-
ure, making the major groove of the RNA accessible to the amino
ide chains of Ro60 (Green et al., 1998). Mutations in the Y RNA
ower stem that remove either bulge, or change the conserved
ucleotide sequence, abolish Ro60 binding (Green et al., 1998;
ruijn et al., 1991). Finally, X-ray crystallography studies show that
o60 is toroidal in shape, binds Y RNAs on its outer surface and
ontains a positively charged central channel that can accommo-
ate single-stranded, but not double-stranded RNA (Stein et al.,
005). Immunoprecipitation experiments have shown that in the
ematode C. elegans the Ro60 orthologue protein, ROP-1, binds
nly a single major RNA, termed CeY RNA (Van Horn et al., 1995).
lthough a recent study suggested that the sbRNA CeN72 interacts
ith ROP-1 in a gel shift assay in vitro (Xiao et al., 2012), neither
eN72 nor any of the other 17 C. elegans sbRNAs were identiﬁed in
OP-1 immunoprecipitates from worm extracts (Van Horn et al.,
995). Consistent with these observations, it was suggested that
he CeY RNA is an outlier of the sbRNA family and that it may  have
ndergone a functional specialisation towards RoRNP-related func-
ions in nematodes (Boria et al., 2010). In prokaryotes, the Ro60
rthologue protein Rsr binds to the lower stem of DrY RNA in D.
adiodurans and Yrl RNAs in Salmonella and M. smegmatis (Chen
t al., 2013, 2014).
La protein is a 50 kDa auto-antigen found complexed with a sub-
et of RoRNPs (Hendrick et al., 1981). La is required for accurate
nd efﬁcient termination of RNA polymerase III transcription, and
inds to the 3′ polyuridine tail of newly synthesised RNAs in the
ucleus (Stefano, 1984). While most mature RNA transcripts lose
heir polyuridine tail, Y RNAs retain theirs (Fig. 1), and so can main-
ain association with La. La is implicated in the nuclear retention of
 RNAs and protecting RNAs from exonucleolytic cleavage (Wolin
nd Cedervall, 2002).
RoRNPs are currently implicated in non-coding RNA quality con-
rol, RNA stability and in cellular responses to stress in several
rganisms (Sim and Wolin, 2011). Ro60 binds aberrant non-coding
NAs such as misfolded 5S rRNA or U2 snRNA in a range of species,
ncluding X. laevis, C. elegans and Mus  musculus (Chen et al., 2003;
abbe et al., 1999a,b; O’Brien and Wolin, 1994). C. elegans lacking
OP-1 are viable, but these deletion strains show defects in dauer
arvae formation, an alternative developmental stage induced by
tarvation or stress that allows them to survive unfavourable envi-
onmental conditions (Labbe et al., 1999b, 2000). Furthermore,
ouse cells and D. radiodurans upregulate and accumulate RoRNPs
n response to ultraviolet (UV) irradiation and both cell types lack-
ng Ro60 have decreased survival following UV irradiation (Chen
t al., 2000, 2003; Xue et al., 2003). In D. radiodurans, the Ro60
rthologue protein Rsr also has a role in heat-stress-induced rRNA
aturation and starvation-induced rRNA decay (Chen et al., 2007;
urtmann and Wolin, 2010). Ro60 binding to misfolded non-
oding RNAs is not largely sequence speciﬁc, indicating that Ro60
ould potentially bind a wide range of RNAs (Fuchs et al., 2006).
t has therefore been proposed that RoRNPs function as cellular
tress sensors, which scavenge and process aberrant non-coding
NAs that fail to associate with their cognate RNA-binding proteins
Fuchs et al., 2006; Hogg and Collins, 2007).
Genetic deletion studies have established that Ro60 protein
nd its orthologues ROP-1 and Rsr in nematodes and prokaryotes, Biochemistry & Cell Biology 66 (2015) 20–29 23
respectively, are not essential for cell proliferation, or the viability
and development of the unperturbed organism (Chen et al., 2000,
2003; Labbe et al., 1999b; Xue et al., 2003). However, these dele-
tions of Ro60 and its orthologues resulted in signiﬁcant reductions
in the levels of soluble eukaryotic or prokaryotic Y RNAs. It has
therefore been concluded from these studies that Ro60 proteins
play a functional role in the stability of their associated Y RNAs.
The precise role of Y RNAs in vertebrate RoRNPs has proved
controversial. Structural and biochemical studies have shown that
misfolded RNAs insert through the Ro60 cavity and also bind to the
Ro60 outer surface at a region that partially overlaps with the Y
RNA-binding domain (Fuchs et al., 2006; Stein et al., 2005). Since
Y RNAs bind Ro60 in a sequence-speciﬁc manner and with higher
afﬁnity than misfolded RNAs, it has been suggested that a bound
Y RNA could sterically bock misfolded RNA binding to Ro60 (Fuchs
et al., 2006; Stein et al., 2005). However, all four human Y RNAs bind
to Ro60 and La, but only hY5 RNA co-puriﬁed with a common tar-
get of RNA quality control, 5S rRNA, via ribosomal protein L5 (Hogg
and Collins, 2007). This work suggested that hY5-RoRNPs interact
with target 5S-L5 RNPs, so that speciﬁc Y RNAs might themselves
modulate the recruitment of misfolded or variant non-coding RNAs
to RoRNPs. A uniﬁed model has been proposed in which Y RNAs
can both positively and negatively regulate the target speciﬁcity
of non-coding RNA quality control mediated by Ro60 (Hogg and
Collins, 2007).
Interestingly, recent studies in D. radiodurans have demon-
strated that prokaryotic Y RNAs regulate both access of the Ro60
orthologue protein Rsr to RNA substrates and also recruit exonucle-
ases involved in their maturation or degradation (Chen et al., 2007,
2013). In D. radiodurans, the prokaryotic DrY RNA tethers Rsr to the
exoribonuclease polynucleotide phosphorylase (PNPase), forming
RYPER (Ro60/Y RNA/PNPase exoribonuclease RNP), an RNA degra-
dation complex that cleaves structured RNAs (Chen et al., 2013;
Wolin et al., 2013). In this specialised RoRNP, the Y RNA acts as a
scaffold linking Rsr with PNPase. It also serves as a gate mediating
the entry of single-stranded RNA substrates into the PNPase cav-
ity, thereby modulating the substrate speciﬁcity of the enzyme and
increasing the effectiveness or RYPER (Chen et al., 2013). It remains
to be seen whether metazoan RoRNPs with their Y RNAs are also
involved in nucleolytic degradation of target RNAs.
Taken together, in these past three-and-a-half decades of
research on the RoRNP, a substantial body of structural and func-
tional data has accumulated that supports a functional role for Y
RNAs in RNA stability and quality control. This allocation of Y RNA
function comes from a sequence- and structure-speciﬁc associa-
tion of pro- and eukaryotic Y RNAs with members of the Ro protein
family. In all cases, this interaction, and thus Y RNA involvement in
a functional role of the resulting RNP, occurs via the evolutionarily
conserved lower stem of the Y RNAs (Fig. 3).
3. Y RNAs are essential factors for the initiation of
chromosomal DNA replication
The ﬁrst direct and essential cellular function that has been
experimentally demonstrated for Y RNAs is their involvement in
the initiation of chromosomal DNA replication (Christov et al., 2006,
2008; Collart et al., 2011; Gardiner et al., 2009; Krude et al., 2009).
In an unbiased approach, Y RNAs were puriﬁed by biochemical
fractionation of a human cell extract as an activity that is essen-
tial for the reconstitution of chromosomal DNA replication in a
cell-free system (Christov et al., 2006). This in vitro system uses
nuclei that are prepared from late G1 phase human cells. Semi-
conservative DNA replication initiates and subsequently elongates
in these nuclei upon the addition of cytosolic extract from prolif-
erating human cells (Krude, 2000; Krude et al., 1997). During its
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tep-wise puriﬁcation, one particular cytosolic replication factor
aintained DNA replication activity over several biochemical steps
hat enriched for poly-anionic factors. Surprisingly, this approach
ed to the puriﬁcation of non-coding Y RNAs as the relevant factor
nd not of a protein, which was expected at the time (Christov et al.,
006). In support of these gain-of-function experiments, speciﬁc
egradation of Y RNAs from unfractionated cytosolic cell extract
brogates the initiation step of DNA replication (Christov et al.,
006; Gardiner et al., 2009; Krude et al., 2009). DNA replication
an then be restored by addition of non-targeted individual human
r vertebrate Y RNAs, but not of other small non-coding RNAs such
s 5S ribosomal RNA or U2 RNA. Therefore, vertebrate Y RNAs are
equired speciﬁcally for DNA replication, and they function redun-
antly with each other in this system. Single molecule analysis of
 RNA depletion and reconstitution experiments provided detailed
nd direct evidence that Y RNAs are required for the initiation step
f DNA replication, leading to the establishment of new DNA repli-
ation forks on human chromosomal DNA (Krude et al., 2009). In
ontrast, Y RNAs are not required for the elongation of existing DNA
eplication forks, and are thus not involved in the DNA copying
echanism as such (Krude et al., 2009). From these experiments,
t has also become clear that Y RNAs do not fulﬁl this important
unction in isolation, but require interaction with other DNA repli-
ation proteins that are also present in the extract (Christov et al.,
006).
Systematic mutagenesis of vertebrate Y RNAs identiﬁed that the
pper stem domain is necessary and also sufﬁcient for Y RNA func-
ion in the initiation of DNA replication (Gardiner et al., 2009). The
pper stem domain is present in all vertebrate Y RNAs and can
hus explain the functional redundancy of vertebrate Y RNAs. This
omain contains a highly conserved central GUG–CAC nucleotide
equence motif (Gardiner et al., 2009) (Fig. 1). A recent structure
nalysis of the upper stem by nuclear magnetic resonance (NMR)
nd far-UV circular dichroism (CD) spectroscopy provided evidence
hat this domain adopts a locally destabilised A-form helix under
hysiological conditions in solution (Wang et al., 2014). The helix
s stabilised by two ﬂanking G–C base pairs, but the central sec-
ion around the highly conserved G–C base pair (i.e. the upper one
f the GUG–CAC motif) is unstable and the accessible bases may
hus be involved in speciﬁc interactions of this domain with as yet
nknown proteins (Wang et al., 2014). Mutations in this sequence
otif abrogate the initiation activity of the Y RNA, concomitant
ith structural perturbation of the upper stem domain (Gardiner
t al., 2009; Wang et al., 2014). Conversely, an insertion of the upper
tem domain into a similarly folded, but inactive, backbone of a
ynthetic RNA results in the full activation of this previously inert
NA as a DNA replication initiation factor (Gardiner et al., 2009).
urthermore, the lower stem and loop domains of Y RNAs are dis-
ensable as they can be entirely removed from the RNA without
oss of DNA replication initiation function (Gardiner et al., 2009).
Importantly, neither Ro60 or La proteins, nor their binding sites
n vertebrate Y RNAs, are required for the initiation of DNA repli-
ation. Immunoprecipitation experiments indicate that ∼50% of Y
NAs in human cell extracts are present outside Ro60 and La RNPs
Langley et al., 2010). Immunodepletion of Ro60 and La RNPs from
uman cytosolic extracts does not inhibit DNA replication in human
ell nuclei (Langley et al., 2010). Furthermore, addition of recombi-
ant puriﬁed Ro60 or La proteins has no effect on DNA replication
n vitro (Langley et al., 2010). Deletion of Ro60 and La binding sites
n the lower stem domain of vertebrate Y RNAs does not inhibit the
NA replication initiation activity of the mutant Y RNAs (Christov
t al., 2006; Gardiner et al., 2009). These ﬁndings indicate that Y
NAs mediate the initiation of DNA replication independently of
oRNPs. Consistent with these in vitro ﬁndings, genetic knockout
f Ro60 in various organisms has no effect on DNA replication or
iability (Chen et al., 2000; Labbe et al., 1999b; Xue et al., 2003). Biochemistry & Cell Biology 66 (2015) 20–29
Vertebrate Y RNAs are also essential for initiation of DNA
replication in vivo. Disruption of Y RNAs by RNAi in proliferat-
ing vertebrate cells in culture blocks DNA replication and cell
proliferation (Christov et al., 2006, 2008; Collart et al., 2011). Inter-
estingly, transfection of a synthetic small double-stranded RNA
derived from the upper stem of hY1 RNA overcomes this inhibition
(Gardiner et al., 2009), demonstrating that its replication func-
tion is indeed responsible for the in vivo phenotype. Furthermore,
functional inactivation of Y RNAs by microinjection of antisense
morpholino oligonucleotides (MOs) into D. rerio or X. laevis embryos
leads to DNA replication inhibition, arrested development and early
embryonic death (Collart et al., 2011), which occurs right after the
mid-blastula transition (MBT) (Langley et al., 2014). Consistent with
a functional role in DNA replication and cell proliferation, Y RNAs
are over-expressed in human solid tumours, when compared with
the corresponding healthy tissues (Christov et al., 2008). Taken
together, these observations establish that Y RNA function is built
on a modular structure of the overall full-length RNA. The essential
function for chromosomal DNA replication in vertebrates can be
ascribed to the short upper stem domain of the vertebrate Y RNAs.
Recently, a family of related small non-coding RNAs, termed
stem-bulge RNAs (sbRNAs), was  identiﬁed in nematode worms
(Aftab et al., 2008; Boria et al., 2010; Deng et al., 2006), and an
sbRNA was also described for the silkworm, B. mori (Duarte et al.,
2015). The genome of C. elegans contains at least 18 sbRNA genes, in
addition to the related aforementioned CeY RNA gene, each with a
putative RNA polymerase III promoter, with many sbRNA genes also
present in other nematode species (Boria et al., 2010). A computa-
tional analysis based on nucleotide sequence and structural motifs
suggested that sbRNAs might be homologues of vertebrate Y RNAs,
the previously described CeY RNA being an outlier of this group
because of a lower sequence conservation compared to the other
sbRNAs (Boria et al., 2010). Y RNAs and sbRNAs share an overall
stem-loop structure containing double-stranded upper and lower
stem domains, as well as a single-stranded internal loop (Boria et al.,
2010). The upper stem domain of sbRNAs, like vertebrate Y RNAs,
contains a highly conserved A/GUG–CAC/U motif (Boria et al., 2010;
Kowalski et al., 2015) (Fig. 3). We have recently shown that sbRNAs
from several nematode species can functionally substitute for ver-
tebrate Y RNAs and support the initiation of chromosomal DNA
replication in vitro, whereas CeY RNA does not (Kowalski et al.,
2015). Importantly, the initiation activity of full-length sbRNAs
was dependent on the upper stem domain and intriguingly, also
on a conserved UUAUC motif in the loop domain, which is also
present in vertebrate Y RNAs (Kowalski et al., 2015). Furthermore,
functional inhibition of sbRNAs in C. elegans resulted in DNA repli-
cation defects and lethality during early embryogenesis (Kowalski
et al., 2015). Collectively, these ﬁndings indicate that sbRNAs are
functional homologues of vertebrate Y RNAs. To date, candidate Y
RNAs or sbRNAs have not been identiﬁed in plants or fungi and it
therefore remains to be seen to what extent the regulation of DNA
replication by small stem-loop RNAs has been conserved during
eukaryotic evolution.
Y RNAs have also been reported in prokaryotes and some other
isolated eukaryotic species (Chen et al., 2000, 2013, 2014; Mosig
et al., 2007; Perreault et al., 2007; Van Horn et al., 1995). The Y RNAs
from C. elegans (CeY RNA), B. ﬂoridae (BfY RNA) and D. radiodurans
(DrY RNA) do not have sequence similarity to vertebrate Y RNAs in
the upper stem domain and they are unable to substitute for ver-
tebrate Y RNAs in DNA replication assays in vitro (Gardiner et al.,
2009). These results indicate that these non-vertebrate Y RNAs do
not fulﬁl the role of vertebrate Y RNAs in DNA replication. Further-
more, D. radiodurans or C. elegans with a deletion in their respective
genes coding for DrY and CeY RNA are viable, so these RNAs are not
essential for DNA replication and viability of the organism (Boria
et al., 2010; Chen et al., 2007). Thus, in C. elegans a large family of
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bRNAs is found, at least some of which function in DNA replica-
ion and do not appear to bind Ro60, whilst the divergent CeY RNA
inds to Ro60 and does not function in DNA replication (Fig. 3).
The mechanism of Y RNA function in the initiation step of DNA
eplication in vertebrates is not yet clear, although several key fea-
ures are emerging. Y RNAs interact biochemically with several
NA replication initiation proteins, including the origin recogni-
ion complex ORC, and initiation proteins Cdc6, Cdt1 and DUE-B
Collart et al., 2011; Zhang et al., 2011). In contrast, hY RNAs do not
nteract biochemically with DNA replication fork proteins includ-
ng the DNA helicase subunits MCM2-7, GINS complex, primase, or
NA polymerases (Zhang et al., 2011). These biochemical interac-
ions would therefore suggest a functional interaction between Y
NAs and the protein machinery of the DNA replication initiation
omplex. Using ﬂuorescently-labelled hY RNAs, it was  shown that
Y RNAs also associate dynamically with unreplicated chromatin
n G1 phase nuclei in vitro, where they co-localise with several DNA
eplication proteins on chromatin before the initiation of DNA repli-
ation, including ORC, Cdt1, MCM2  and Cdc45 (Zhang et al., 2011).
n X. laevis, Y RNA binding to chromatin occurs only after the MBT
nd is ORC-dependent (Collart et al., 2011). Once DNA replication
nitiates in a Y RNA-dependent manner, Y RNAs are locally displaced
rom these initiation sites, and they are consequently absent from
he sites of ongoing DNA synthesis in these nuclei (Zhang et al.,
011). It has therefore been suggested that Y RNAs could function
n a ‘catch-and-release’ mechanism on chromatin in human cells
Zhang et al., 2011), which is consistent with the original ‘licensing
actor’ model of Blow and Laskey (Blow et al., 1987; Laskey et al.,
981). Future experiments are needed to test this hypothesis and
esolve the underlying molecular mechanism of Y RNA function
uring the initiation of chromosomal DNA replication. Questions
o address will include whether or not the upper stem domain
f Y RNAs hybridises with other nucleic acids in order to execute
ts essential function; which are the functionally essential interac-
ing DNA replication proteins and whether Y RNAs activate these
roteins or inactivate any potential repressors.
. Y RNA localisation
In eukaryotes the biogenesis of Y RNAs begins in the nucleus, as
NA polymerase III transcription is terminated. As with other RNA
olymerase III transcripts such as tRNAs or pre-miRNAs, Y RNAs can
e exported to the cytoplasm, or like U snRNAs, they can remain in
he nucleus after transcription.
There are conﬂicting reports on the relative distribution of Y
NAs in the nucleus and cytoplasm of vertebrate cells, likely in
art due to different methodologies used (Hall et al., 2013; Pruijn
t al., 1997; Zhang et al., 2011). Early enucleation and cell frac-
ionation experiments revealed that Y RNAs were predominantly,
r even exclusively, cytoplasmic in cultured mammalian cells and
. laevis oocytes (O’Brien et al., 1993; Peek et al., 1993; Simons
t al., 1994). One study reported more recently that in human and
ouse cells, h/mY1, h/mY3 and hY4 RNAs are found in the cyto-
lasm, whereas hY5 RNA localises to the nucleus (Gendron et al.,
001). In situ hybridisation and ultrastructural analysis by electron
icroscopy, however, showed that Y RNAs are present at discrete
ites in both the nucleus and cytoplasm of cultured human cells
Farris et al., 1997; Matera et al., 1995). Furthermore, in proliferat-
ng human cells hY1, hY3 and hY5 RNAs also localise to the edge
f nucleoli (the perinucleolar compartment) and co-localise with
TB at these sites in the cell nucleus (Matera et al., 1995). Using
uorescently-labelled hY RNAs it was shown that all four hY RNAs
ind chromatin in G1 phase nuclei dynamically from a soluble pool
s the nuclei enter S phase in vitro (Zhang et al., 2011). While hY1,
Y3 and hY4 co-localise with each other and associate mostly with Biochemistry & Cell Biology 66 (2015) 20–29 25
early-replicating euchromatin, hY5 is enriched in nucleoli (Zhang
et al., 2011). The loop domain of hY RNAs modulates this differ-
ential association with chromatin as mutant hY RNAs lacking this
domain bind to chromatin indiscriminately (Zhang et al., 2011). It
remains to be seen if this dynamic chromatin association of Y RNAs
is important for their function in the initiation of DNA replication,
and in how far it is regulated during the cell cycle. In any case, there
is now accumulating evidence that Y RNAs are present in both the
nuclear and cytoplasmic fractions of eukaryotic cells, and that their
relative abundance in these cell compartments most likely reﬂects
the methodologies used for study and/or the physiological state of
the cells.
The export pathways used by Y RNAs are also becoming increas-
ingly well understood. Y RNA export is dependent on the small
GTPase Ran, indicating that exportins likely serve as transport
receptor proteins for Y RNAs (Rutjes et al., 2001). The lower stem
of Y RNAs resembles a dsRNA mini-helix present in other exportin-
5 substrates and exportin-5 was shown to associate in a complex
with hY1 RNA and RanGTP (Gwizdek et al., 2001, 2003). Further-
more, deletion of the lower stem of hY1 RNA results in defective
nuclear export of the mutant RNA in Xenopus oocytes (Rutjes et al.,
2001). Therefore, it seems likely that Y RNAs are exported from the
nucleus in an exportin-5-dependent manner. Direct mechanistic
evidence of a re-import pathway of Y RNAs back into the nucleus
has not been identiﬁed to date.
Ro60 binding protects Y RNAs from exonucleolytic degradation
and is required for stable accumulation of Y RNAs in a range of
species (Chen and Wolin, 2004). It has been proposed that one
function of mammalian Y RNAs is to regulate the subcellular local-
isation of Ro60 (Sim and Wolin, 2011). Ro60 is present in both the
nucleus and cytoplasm of cells and it has been shown that Y RNAs
can inﬂuence this distribution (Sim and Wolin, 2011). In mouse
cells, Y RNA binding to Ro60 occludes a nuclear localisation signal
on the Ro60 surface, thereby retaining RoRNPs in the cytoplasm
(Sim et al., 2009). Another study has demonstrated that Ro60 bind-
ing is a prerequisite for efﬁcient nuclear export of Y RNAs in X. laevis
oocytes (Simons et al., 1996).
The intracellular localisation of Y RNAs changes under condi-
tions of cellular stress (Chen and Wolin, 2004). Both Ro60 and Y
RNAs accumulate in the nucleus after UV irradiation or oxidative
stress in several species (Chen et al., 2000, 2003; Sim et al., 2009,
2012). This is consistent with a role for nuclear Ro60-Y RNA com-
plexes in cellular stress responses. However, it could also arise
from stress-induced inhibition of the RanGTP gradient, resulting
in defective nuclear export and thus nuclear accumulation (Köhn
et al., 2013).
Mammalian Y RNAs can also be selectively packaged into
viruses. This has been demonstrated for the human immunode-
ﬁciency virus type 1 (HIV-1) and Moloney murine leukaemia virus
(Garcia et al., 2009; Wang et al., 2007). This process does not require
Ro60 binding and likely occurs during early stages of Y RNA biogen-
esis when nascent Y RNAs are present in the nucleus (Wang et al.,
2007). It is currently unknown whether Y RNAs are involved in
retroviral function.
Unlike vertebrate Y RNAs, the intracellular localisations of
nematode sbRNAs and CeY RNA have not yet been investigated.
It therefore remains to be seen whether the functional homology
between vertebrate Y RNAs and nematode sbRNAs is also reﬂected
in a similar distribution of these nematode sbRNAs in the nuclear
and cytoplasmic fractions of the cell.5. Y RNA loop domain-binding proteins
Recently, several novel Y RNA-binding proteins have been iden-
tiﬁed in eukaryotic cells. It was shown using gel ﬁltration that Y
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NPs present in human cell extracts range in size from 150 to
50 kDa, indicating that Y RNAs can associate with multiple pro-
eins simultaneously (Fabini et al., 2000). However, apart from the
anonical Y RNA-binding proteins Ro60 and La, the interactions
etween other cellular proteins and Y RNAs are currently poorly
haracterised.
Several proteins interact with Y RNAs through the loop domain,
hich is the least conserved domain in Y RNAs; it is heterogeneous
n structure and varies in nucleotide sequence between individual
 RNAs (Fig. 1) (Farris et al., 1999; Teunissen et al., 2000). The loop
omains of hY1, hY3 and hY5 RNAs are pyrimidine-rich, and in hY1
nd hY3 RNAs, contain stretches of poly-pyrimidine sequences. The
oop domains of Y RNAs can interact with a different set of proteins
o form distinct Y RNPs (Bouffard et al., 2000; Fabini et al., 2001;
ogg and Collins, 2007). The loop domain may  therefore specialise
ndividual Y RNAs for speciﬁc cellular functions (Hogg and Collins,
007).
In human cells, several Y RNA-loop-binding proteins have been
dentiﬁed, including nucleolin, PTB/hnRNP I, hnRNP K and ZBP1
Köhn et al., 2013). Nucleolin binds pyrimidine-rich stretches in
he loop domain of Y RNAs in human cells, and while it preferen-
ially associates with hY1 and hY3, it is present in stable cytosolic
NPs with all four hY RNAs (Fabini et al., 2001; Langley et al., 2010).
ucleolin is involved in many metabolic processes, including rRNA
rocessing, ribosome biogenesis and nucleo-cytoplasmic transport
Ginisty et al., 1999). Cytosolic nucleolin RNPs are distinct from
o60 and La RNPs and immunodepletion of nucleolin RNPs from
ytosolic extracts does not inhibit DNA replication initiation in
uman cell nuclei (Langley et al., 2010). Therefore the interaction
etween Y RNAs and soluble nucleolin is not required for Y RNA
unction in this process (Langley et al., 2010).
PTB and hnRNP K bind preferentially to poly-pyrimidine tracts
n the loop domains of hY1 and hY3 RNAs, like nucleolin, but their
ssociation with hY4 and hY5 RNAs has not been detected (Fabini
t al., 2001; Fouraux et al., 2002). Efﬁcient binding of PTB and hnRNP
 to Y RNAs also likely requires La, because deletion of the La bind-
ng site signiﬁcantly decreases binding of both proteins to the RNA
Fabini et al., 2001). PTB and hnRNP K are both involved in several
spects of RNA processing and are thought to shuttle between the
ucleus and the cytoplasm (Krecic and Swanson, 1999). PTB, hnRNP
 and La function as RNA chaperones in vitro and mediate RNA fold-
ng without a requirement for ATP consumption (Belisova et al.,
005). Since Y RNA binding to these proteins inhibits their RNA
haperone activity, it has been proposed that Y RNAs mediate the
ransport of hnRNP K, PTB and La to speciﬁc targets, before releas-
ng the proteins to execute their function (Belisova et al., 2005).
BP1 interacts with mouse Y1 and Y3 RNAs via their loop domains
Köhn et al., 2013; Sim et al., 2012). Depletion of ZBP1 results in
ccumulation of Y3 RNA in mouse cell nuclei, indicating that ZBP1
s involved in nuclear export of Y RNPs (Sim et al., 2012).
All four human Y RNAs associate with the antiviral cytidine
eaminase APOBEC3G, which is also a component of Ro60 and La
NPs (Chiu et al., 2006; Gallois-Montbrun et al., 2008). Although the
unction of these Y RNPs is unknown, it has been speculated that
POBEC3G could be involved in RNA editing of Y RNAs to modulate
heir function (Chiu et al., 2006; Köhn et al., 2013).
There are also several proteins that bind preferentially or exclu-
ively to Y5 RNAs, indicating a specialised role for this Y RNA.
oRNP binding protein I (RoBPI) mainly associates with hY5 RNA
n human cells (Bouffard et al., 2000) but also binds hY1 and
Y3 RNAs (Hogg and Collins, 2007). RoBPI is a DNA- and RNA-
inding protein involved in several nuclear processes, such as
ranscription and RNA splicing (Page-McCaw et al., 1999). In addi-
ion, Interferon-induced protein with tetratricopeptide repeats 5
IFIT5) only interacts with hY5 RNA (Hogg and Collins, 2007). Ribo-
omal protein L5 also interacts speciﬁcally with hY5 RNA (Hogg Biochemistry & Cell Biology 66 (2015) 20–29
and Collins, 2007). The L5 protein forms complexes with 5S rRNA
(Steitz et al., 1988) and Y5 RNA also associates with 5S rRNA, with a
strong preference for a misfolded variant (Hogg and Collins, 2007).
Together with the observed enrichment of hY5 in nucleoli (Zhang
et al., 2011), these results indicate that hY5 RNA could be involved
in rRNAs biogenesis (Hogg and Collins, 2007).
The identiﬁcation of these non-canonical Y RNA-binding pro-
teins, many of which show preferential binding to speciﬁc Y RNAs,
indicates that Y RNAs are likely incorporated into multiple, distinct
RNPs to carry out specialised functions (Bouffard et al., 2000; Fabini
et al., 2001; Hogg and Collins, 2007; Langley et al., 2010). It is also
possible that Y RNAs sequester multiple cellular proteins until they
are needed, for example in response to stress (Köhn et al., 2013). In
addition, the localisation of Y RNAs is also inﬂuenced by these inter-
acting proteins (Köhn et al., 2013; Zhang et al., 2011). In conclusion,
the loop domains of eukaryotic Y RNAs attract many divergent
binding proteins and further work is required to understand mech-
anistically any potential functional roles for the resulting different
Y RNP complexes.
6. Y RNA-derived small RNAs
Recently, a plethora of deep sequencing studies in eukaryotes
have identiﬁed small RNA fragments derived from longer RNAs
(Rother and Meister, 2011; Tuck and Tollervey, 2011). Accumu-
lating evidence suggests that these RNA fragments, while derived
from pre-existing small non-coding RNAs, are themselves physio-
logically relevant in both healthy and diseased cells (Dhahbi, 2014;
Hall and Dalmay, 2013).
High levels of Y RNA-derived small RNAs (YsRNAs) of 22–36
nucleotides are produced in apoptotic cells (Rutjes et al.,
1999). Immunoprecipitation experiments have revealed that these
YsRNAs are bound to Ro60 and La proteins, suggesting that the
binding sites of these proteins in the lower stem domain of Y RNAs
are protected from the nucleolytic degradation process (Rutjes
et al., 1999). It remains to be seen whether the upper stem domain
of Y RNAs, which is required for Y RNA functionality in DNA repli-
cation and cell proliferation, is actively targeted during apoptosis.
YsRNAs are also detected in proliferating cells, both cancerous
and non-cancerous, at levels similar to that of known miRNAs
(Nicolas et al., 2012). YsRNAs are also found in the brain, retina
and other healthy mammalian tissues, as well as in a range of
tumours (Chen and Heard, 2013; Meiri et al., 2010; Verhagen and
Pruijn, 2011; Yamazaki et al., 2014). Some of these YsRNAs were
initially mis-annotated as a novel type of miRNA generated by
the processing of full-length Y RNAs (Meiri et al., 2010; Verhagen
and Pruijn, 2011). However, it has subsequently been shown that
YsRNA biogenesis is independent of the canonical miRNA biogen-
esis pathway. YsRNAs do not associate with Argonaute proteins
(Chen and Heard, 2013; Nicolas et al., 2012), and the generation of
YsRNAs appears to be independent of Dicer (Langenberger et al.,
2013). Furthermore, in contrast to miRNAs, YsRNAs do not have
gene silencing activity in the luciferase reporter assay (Meiri et al.,
2010). The role of these intracellular YsRNAs is currently unknown.
YsRNAs, along with tRNA fragments, have been recently iden-
tiﬁed as highly abundant small RNAs circulating in the blood of
humans and other mammals (Dhahbi, 2014). Circulating YsRNAs
of 25–33 nucleotides are present in human blood in multiple
forms, including within vesicles and as cell-free RNP complexes
of 100–300 kDa (Dhahbi, 2014; Dhahbi et al., 2013, 2014). These
YsRNAs are derived from the 5′ and 3′ termini of full-length
Y RNAs by cleavage within the internal loop domain (Dhahbi et al.,
2013, 2014). The levels of these 5′ and 3′-Y RNA and 5′-tRNA-
derived fragments were found to be signiﬁcantly different in a
group of breast cancer patients compared to healthy individuals,
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uggesting that these fragments may  have some diagnostic value
s cancer biomarkers (Dhahbi et al., 2014). Interestingly, many of
he Y RNAs from which the fragments are derived have previously
een annotated as Y RNA pseudogenes, and therefore not thought
o be expressed or processed (Dhahbi et al., 2013, 2014). Since YsR-
As have no known functions, the signiﬁcance of the pseudogene
xpression is unclear.
YsRNAs and full-length Y RNAs have also been detected in vesi-
les released by mouse immune cells (Nolte-’t Hoen et al., 2012)
nd YsRNAs comprise a substantial fraction of the RNA component
f exosome vesicles present in human semen (Vojtech et al., 2014).
he function of these extracellular YsRNAs is currently unknown
nd whilst it has been speculated that YsRNAs are speciﬁcally
rocessed and secreted as part of an as yet undeﬁned signalling
rocess (Dhahbi, 2014), these RNA fragments could alternatively
ust be passive, stable degradation products of highly abundant
ellular Y RNAs. However, it is an intriguing possibility that small
NAs could mediate intercellular physiological signals (Chen et al.,
012; Hoy and Buck, 2012; Sarkies and Miska, 2014; Valadi et al.,
007) and therefore the clinical potential of YsRNAs as diagnos-
ic biomarkers or blood-delivered therapy targets remains an open
nd exciting possibility.
. Conclusions
Y RNAs are small non-coding RNAs involved in a range of
ellular processes, including DNA replication, RNA stability and
ellular stress responses. The modular domains of Y RNAs medi-
te their distinct cellular roles (Figs. 1–3). The upper stem domain
f vertebrate Y RNAs and homologous nematode sbRNAs is essen-
ial for the initiation of chromosomal DNA replication. The lower
tem is required for Ro60 binding and hence is involved in stress
esponses, RNA surveillance, stability control and RoRNP-mediated
NA degradation across several eukaryotic and prokaryotic species.
urthermore, the evolutionary conservation of the structure and
ucleotide sequence of the upper and lower stem domains is tightly
orrelated to the conservation of Y RNA functions across species,
ndicative of high selective pressure on the Y RNA domains. The loop
omain, although part of the conserved overall secondary structure
f Y RNAs, is highly varied in its nucleotide sequence. This might
acilitate functional sub-specialisation of different Y RNA molecules
ithin the same species. This RNA module-based strategy might
rovide a way of regulating and separating important cellular func-
ions of the small non-coding Y RNAs. With the recent emergence of
n expansive landscape of pervasive transcription and non-coding
NAs in mammalian cells (Clark et al., 2011; Iyer et al., 2015),
his principle also has direct implications for non-coding RNA
Box 1
Outstanding questions
• How do Y RNAs regulate the initiation of DNA replication in
vertebrates?
• Is the requirement for small stem-loop RNAs in the initiation
of chromosomal DNA replication conserved beyond verte-
brates and nematodes?
• Are Y RNAs in RoRNPs involved in RNA degradation in ver-
tebrates?
• What are the functions of non-canonical Y RNA-binding pro-
teins and their associated RNPs?
• Are small RNA fragments derived from mammalian Y RNAs
of functional signiﬁcance and could they be used therapeu-
tically?
• As a general outlook, why have so many  different biological
functions been compressed into such a small RNA molecule? Biochemistry & Cell Biology 66 (2015) 20–29 27
evolution. As seen with Y and sbRNAs across eukaryotes and
prokaryotes, each modular RNA domain can evolve separately and
thus pave the way  for functional divergence and specialisation of
non-coding RNAs (Fig. 3). Since the discovery of Y RNAs in 1981,
much progress has been made in elucidating their binding proteins,
evolutionarily conservation and important cellular roles. However,
many key questions remain, which provide opportunity for exciting
further growth in the ﬁeld of non-coding Y RNAs (Box 1).
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